CONTACT US   |  (864) 397-5101

Researchers seek to unravel the mystery of susceptibility to drug addiction

Clemson

Why do some people become addicted to drugs and alcohol while others don’t? 

What role does genetics play? Which genes or networks of genes are key?

Geneticists Trudy Mackay and Robert Anholt lead a team of researchers from the Clemson University Center for Human Genetics working to unravel those mysteries using Drosophila melanogaster, or the common fruit fly. 

The work, funded by a five-year, nearly $2.5 million grant renewal from the National Institutes of Health’s National Institute on Drug Abuse (NIDA), builds upon previous work by Mackay and Anholt to identify the genetic underpinnings of cocaine and methamphetamine consumption. The research could lay the groundwork for developing new drugs or repurposing already approved drugs to treat or prevent addiction in humans. 

Costly problem

Substance abuse is one of the costliest public health problems in the nation. The U.S. Department of Health and Human Services estimates Illicit drug use accounts for $193 billion in health care, productivity loss, crime, incarceration and drug enforcement.

Scientists know genetics plays a role in human susceptibility to drug addiction.

Man holding a test tube with fruit flies inside
Robert Anholt holds a test tube with fruit flies inside.

“Not everybody becomes addicted. Some people become very easily addicted while others can be social drinkers or users and never become addicted, so we know there’s a genetic component,” said Anholt, Provost’s Distinguished Professor of Genetics and Biochemistry.

The researchers use fruit flies in their research because approximately 70 percent of fruit fly genes have human counterparts. Plus, unlike humans, the flies’ genetic background and environment can be precisely controlled. 

In a previous study, Mackay and Anholt found cocaine use elicits rapid, widespread changes in gene expression throughout the fruit fly brain — and that the differences are more pronounced in males than females.

Making a choice

That study allowed male and female flies to ingest a fixed amount of sucrose or sucrose supplemented with cocaine over no more than two hours. Researchers then dissected the brains and dissociated them into single cells. Using next-generation sequencing technology, they constructed an atlas of gene expression changes after cocaine exposure.

fruit flies under a microscope
Fruit flies make good model organisms because their environment can be precisely controlled. Image credit: College of Science/Robert P. Bradley.

“Through the previous grant, we learned a lot about the genetic basis of flies consuming cocaine or sucrose when they weren’t given a choice. But as the field is evolving, it is thought that preference is a better model of what could be considered addictive behaviors in humans,” said Mackay, the director of the CHG and the Self Family Endowed Chair in Human Genetics.

Mackay’s lab developed the Drosophila melanogaster Genetic Reference Panel (DGRP), which consists of inbred fly lines with fully sequenced genomes derived from a natural population. The DGRP allows researchers to use naturally occurring variations to examine genetic variants that contribute to susceptibility to various stressors.

Using those fly lines and a high throughput method CHG Ph.D. student Spencer Hatfield and former postdoctoral fellow Joshua Walters developed to measure preference (choosing sucrose containing cocaine over plain sucrose when given the choice), the researchers will map variants associated with preference and the genes associated with those variants.

Real measure of addiction

“We can look at those lines that have an innate preference and ask whether we can further develop the model for addiction. In other words, if they are exposed repeatedly, will they start to prefer it more and develop adverse behavioral or physiological reactions? And despite that adversity, will they continue to show a preference for cocaine? That will be a real measure of addiction,” Anholt said. 

A small-scale Mackay lab study involving 46 genetically diverse lines of flies showed a genetic variation for preference that changed over time.

“That shows that the larger experiment we’re doing now is likely to succeed,” Mackay said. “It showed that, even on a small scale, there is genetic variation.”

Genes identified as important in cocaine preference that have human counterparts could be potential targets for therapeutics that could treat or prevent addiction.


The College of Science pursues excellence in scientific discovery, learning, and engagement that is both locally relevant and globally impactful. The life, physical and mathematical sciences converge to tackle some of tomorrow’s scientific challenges, and our faculty are preparing the next generation of leading scientists. The College of Science offers high-impact transformational experiences such as research, internships and study abroad to help prepare our graduates for top industries, graduate programs and health professions. clemson.edu/science 

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.